BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 8602647)

  • 1. Case report: strongyloidiasis refractory to treatment with ivermectin.
    Ashraf M; Gue CL; Baddour LM
    Am J Med Sci; 1996 Apr; 311(4):178-9. PubMed ID: 8602647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fatal relapse of disseminated strongyloidiasis in an HIV-positive patient, despite ivermectin treatment.
    Mattioni S; Valin N; Cracco C; Thellier M; Danis M; Caumes E
    Ann Trop Med Parasitol; 2008 Dec; 102(8):693-8. PubMed ID: 19000386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Image of the month. Strongyloides stercoralis larvae.
    Hokama A; Adaniya H; Saito A
    Gastroenterology; 1998 Jan; 114(1):6, 230. PubMed ID: 9428211
    [No Abstract]   [Full Text] [Related]  

  • 4. Manifestations, diagnosis, and treatment of Strongyloides stercoralis infection.
    Segarra-Newnham M
    Ann Pharmacother; 2007 Dec; 41(12):1992-2001. PubMed ID: 17940124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Parasite-specific serum IgG following successful treatment of endemic strongyloidiasis using ivermectin.
    Lindo JF; Atkins NS; Lee MG; Robinson RD; Bundy DA
    Trans R Soc Trop Med Hyg; 1996; 90(6):702-3. PubMed ID: 9015524
    [No Abstract]   [Full Text] [Related]  

  • 6. Strongyloides hyperinfection: a treatment dilemma.
    Miller MA; Church LW; Salgado CD
    Am J Med Sci; 2008 Oct; 336(4):358-61. PubMed ID: 18854683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stronglyoides stercoralis infection from pancreas allograft: case report.
    Ben-Youssef R; Baron P; Edson F; Raghavan R; Okechukwu O
    Transplantation; 2005 Oct; 80(7):997-8. PubMed ID: 16249752
    [No Abstract]   [Full Text] [Related]  

  • 8. Strongyloides hyperinfection syndrome complications: a case report and review of the literature.
    Najmuddin A; Hadique S; Parker J
    W V Med J; 2012; 108(1):32-8. PubMed ID: 25134190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Disseminated strongyloidiasis].
    Nozais JP; Thellier M; Datry A; Danis M
    Presse Med; 2001 Apr; 30(16):813-8. PubMed ID: 11388155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized clinical trial on ivermectin versus thiabendazole for the treatment of strongyloidiasis.
    Bisoffi Z; Buonfrate D; Angheben A; Boscolo M; Anselmi M; Marocco S; Monteiro G; Gobbo M; Bisoffi G; Gobbi F
    PLoS Negl Trop Dis; 2011 Jul; 5(7):e1254. PubMed ID: 21814588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systemic strongyloidiasis complicating HIV: a promising response to ivermectin.
    Heath T; Riminton S; Garsia R; MacLeod C
    Int J STD AIDS; 1996 Jul; 7(4):294-6. PubMed ID: 8876364
    [No Abstract]   [Full Text] [Related]  

  • 12. [Hemodialysis and strongyloidiasis: a presumed cause of eosinophilia able to mask the other].
    Saïd S; Nevez G; Morinière P; Fournier A; Raccurt CP
    Nephrologie; 1999; 20(6):343-6. PubMed ID: 10592937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment strategies in controlling strongyloidiasis.
    Satoh M; Kokaze A
    Expert Opin Pharmacother; 2004 Nov; 5(11):2293-301. PubMed ID: 15500376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fatal outcome of a hyperinfection syndrome despite successful eradication of Strongyloides with subcutaneous ivermectin.
    Hauber HP; Galle J; Chiodini PL; Rupp J; Birke R; Vollmer E; Zabel P; Lange C
    Infection; 2005 Oct; 33(5-6):383-6. PubMed ID: 16258873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gastric strongyloidiasis and infection by the human T cell lymphotropic virus type 1 (HTLV-1).
    Lambertucci JR; Leão FC; Barbosa AJ
    Rev Soc Bras Med Trop; 2003; 36(4):541-2. PubMed ID: 12937738
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatment failure in intestinal strongyloidiasis: an indicator of HTLV-I infection.
    Terashima A; Alvarez H; Tello R; Infante R; Freedman DO; Gotuzzo E
    Int J Infect Dis; 2002 Mar; 6(1):28-30. PubMed ID: 12044298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of Strongyloides stercoralis: a puzzling parasite.
    Luvira V; Watthanakulpanich D; Pittisuttithum P
    Int Health; 2014 Dec; 6(4):273-81. PubMed ID: 25173343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Infection due to Strongyloides stercoralis: epidemiological, clinical, diagnosis findings and outcome in 30 patients].
    Corti M; Villafañe MF; Trione N; Risso D; Abuín JC; Palmieri O
    Rev Chilena Infectol; 2011 Jun; 28(3):217-22. PubMed ID: 21879146
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pulmonary strongyloidiasis in a patient receiving prednisolone therapy.
    Namisato S; Motomura K; Haranaga S; Hirata T; Toyama M; Shinzato T; Higa F; Saito A
    Intern Med; 2004 Aug; 43(8):731-6. PubMed ID: 15468976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Strongyloides stercoralis infection in a patient with sickle cell disease.
    Ferastraoaru DE; Jariwala NN; Jariwala SP
    Ann Trop Med Parasitol; 2011 Dec; 105(8):647-50. PubMed ID: 22325823
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.